A new biomedical institute called Arena BioWorks is being launched in Cambridge’s Kendall Square, with $500 million in private funding. The institute aims to shorten the time from research to life-saving medicines by combining drug discovery and company creation under one roof. This model challenges the traditional separation of academic research and venture-backed drug development. Backed by investors like Steve Pagliuca and Michael Dell, the institute has recruited top scientists with attractive compensation packages. The company plans to create significant impact in the biomedical field and has shown strong support from influential investors.
Source link
Arena BioWorks launches in Cambridge to speed drug discovery
